梭杆菌门
梭杆菌
川崎病
微生物学
志贺氏菌
肠道菌群
生物
志贺氏菌病
发病机制
普雷沃菌属
免疫学
链球菌
病因学
抗生素
微生物群
医学
细菌
16S核糖体RNA
病理
拟杆菌
内科学
放线菌门
动脉
生物信息学
沙门氏菌
遗传学
作者
Imran Khan,Xiaoang Li,Betty Yuen Kwan Law,Ka In U,Bao Quan Pan,Cheng Lei,W.L. Wendy Hsiao
出处
期刊:Future Microbiology
[Future Medicine]
日期:2020-05-01
卷期号:15 (8): 591-600
被引量:15
标识
DOI:10.2217/fmb-2019-0301
摘要
Aim: Here, we hypothesize that dysbiotic gut microbiota might contribute to the development of Kawasaki disease (KD), a pediatric disease with unknown etiology. This is the second report on gut microbiota composition in KD patients. Materials & results: 16S amplicon sequencing was performed on fecal DNA samples and revealed predominance of bacterial pathogens, such as Fusobacterium, Neisseria, Shigella and Streptococcus, in the gut of KD patients, but absent or suppressed after immunoglobulin/antibiotics therapy. In addition, beneficial bacteria propagated after the therapy. Conclusion: We conclude that prevalence of Fusobacteria, Shigella and Streptococcus might contribute to KD pathogenesis.
科研通智能强力驱动
Strongly Powered by AbleSci AI